{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:14:23Z","timestamp":1780920863484,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":55,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011696","name":"Shahed University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011696","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101154","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:15:42Z","timestamp":1772093742000},"page":"101154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Assessing the correlation between CD15 expression and gleason score and grade groups in prostate adenocarcinoma: A cross-sectional study"],"prefix":"10.1016","volume":"47","author":[{"given":"Mahdi","family":"Karamvand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mahdi","family":"Mehrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8817-2215","authenticated-orcid":false,"given":"Mohammadreza","family":"Jalali Nadoushan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101154_bib0001","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev.pathol.1.110304.100047","article-title":"Integrative biology of prostate cancer progression","volume":"1","author":"Tomlins","year":"2006","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101154_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11061552","article-title":"Novel histopathological biomarkers in prostate cancer: implications and perspectives","volume":"11","author":"Kie\u0142b","year":"2023","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101154_bib0003","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101154_bib0004","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41416-022-02136-3","article-title":"Five-year survival of patients with late-stage prostate cancer: comparison of the Military Health System and the U.S. general population","volume":"128","author":"Lin","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101154_bib0005","doi-asserted-by":"crossref","first-page":"140","DOI":"10.6004\/jnccn.2024.0019","article-title":"NCCN guidelines\u00ae insights: prostate cancer, version 3.2024","volume":"22","author":"Schaeffer","year":"2024","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101154_bib0006","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3390\/metabo11030181","article-title":"Advances and perspectives in prostate cancer biomarker discovery in the last 5 years through tissue and urine metabolomics","volume":"11","author":"Lima","year":"2021","journal-title":"Metabolites"},{"issue":"21","key":"10.1016\/j.ctarc.2026.101154_bib0007","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1200\/JCO.2008.20.4669","article-title":"Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?","volume":"27","author":"Stark","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101154_bib0008","doi-asserted-by":"crossref","first-page":"363","DOI":"10.30699\/ijp.2023.2002657.3116","article-title":"Evaluation of cytokeratin-7 and cytokeratin-19 expression relationship with Gleason score in prostatic adenocarcinoma","volume":"18","author":"Soltanipur","year":"2023","journal-title":"Iran. J. Pathol."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101154_bib0009","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma","volume":"44","author":"Van Leenders","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101154_bib0010","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.4049\/jimmunol.1502033","article-title":"CD Nomenclature 2015: human leukocyte differentiation antigen workshops as a driving force in immunology","volume":"195","author":"Engel","year":"2015","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101154_bib0011","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14092203","article-title":"Prognostic and therapeutic role of CD15 and CD15s in cancer","volume":"14","author":"Szlasa","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ctarc.2026.101154_bib0012","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3389\/fimmu.2017.01878","article-title":"E-selectin ligands in the human mononuclear phagocyte system: implications for infection, inflammation, and immunotherapy","volume":"8","author":"Silva","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101154_bib0013","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10585-007-9096-4","article-title":"Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis","volume":"25","author":"Gout","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101154_bib0014","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1203\/00006450-199602000-00001","article-title":"Adhesion molecules-their role in health and disease","volume":"39","author":"Etzioni","year":"1996","journal-title":"Pediatr. Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101154_bib0015","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s42003-021-02295-8","article-title":"FUT6 deficiency compromises basophil function by selectively abrogating their sialyl-Lewis x expression","volume":"4","author":"Puan","year":"2021","journal-title":"Commun. Biol."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101154_bib0016","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nchembio.116","article-title":"CD15 expression in human myeloid cell differentiation is regulated by sialidase activity","volume":"4","author":"Gadhoum","year":"2008","journal-title":"Nat. Chem. Biol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101154_bib0017","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3390\/cancers12061413","article-title":"Prognostic implications of CD10 and CD15 expression in papillary thyroid carcinoma","volume":"12","author":"Oh","year":"2020","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101154_bib0018","first-page":"1817","article-title":"Up-regulation of the oligosaccharide sialyl LewisX: a new prognostic parameter in metastatic prostate cancer","volume":"55","author":"J\u00f8rgensen","year":"1995","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101154_bib0019","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0046-8177(95)90220-1","article-title":"Sialyl-Lewisx and related carbohydrate antigens in the prostate","volume":"26","author":"M\u00e5rtensson","year":"1995","journal-title":"Hum. Pathol."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101154_bib0020","first-page":"1544","article-title":"Enhanced expression of \u03b1 (1, 3)-fucosyltransferase genes correlates with E-selectin-mediated adhesion and metastatic potential of human lung adenocarcinoma cells","volume":"58","author":"Mart\u00edn-Satu\u00e9","year":"1998","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101154_bib0021","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1530\/ERC-16-0569","article-title":"Glycosylation is a global target for androgen control in prostate cancer cells","volume":"24","author":"Munkley","year":"2017","journal-title":"Endocr.-Relat. Cancer"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101154_bib0022","article-title":"Single-cell proteomics defines the cellular heterogeneity of localized prostate cancer","volume":"3","author":"Roditi","year":"2022","journal-title":"Cell Rep. Med."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101154_bib0023","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1023\/A:1018502424487","article-title":"Sialyl-Lewis-X, Gleason grade and stage in non-metastatic human prostate cancer","volume":"14","author":"Idikio","year":"1997","journal-title":"Glycoconj. J."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101154_bib0024","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.ccell.2024.08.018","article-title":"Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer","volume":"42","author":"Cal\u00ec","year":"2024","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101154_bib0025","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1038\/s41467-022-34871-9","article-title":"ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101154_bib0026","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/modpathol.3880220","article-title":"Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma","volume":"13","author":"Genega","year":"2000","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ctarc.2026.101154_bib0027","article-title":"Overexpression of sialyl Lewisa carrying mucin-type glycoprotein in prostate cancer cell line contributes to aggressiveness and metastasis","volume":"281","author":"Manasa","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"7714","key":"10.1016\/j.ctarc.2026.101154_bib0028","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41586-018-0266-0","article-title":"IL-23 secreted by myeloid cells drives castration-resistant prostate cancer","volume":"559","author":"Calcinotto","year":"2018","journal-title":"Nature"},{"issue":"7989","key":"10.1016\/j.ctarc.2026.101154_bib0029","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41586-023-06696-z","article-title":"Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance","volume":"623","author":"Guo","year":"2023","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101154_bib0030","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1159\/000541881","article-title":"The immune microenvironment in prostate cancer: a comprehensive review","volume":"103","author":"Novysedlak","year":"2025","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101154_bib0031","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10719-020-09912-4","article-title":"The physiological and pathological roles and applications of sialyl Lewis x, a common carbohydrate ligand of the three selectins","volume":"37","author":"Jin","year":"2020","journal-title":"Glycoconj. J."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226000651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226000651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:55:17Z","timestamp":1780919717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226000651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":31,"alternative-id":["S2468294226000651"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101154","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the correlation between CD15 expression and gleason score and grade groups in prostate adenocarcinoma: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101154"}}